This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Ko Da Pharmaceuticals Co., Ltd.. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: The Innovative Contributions of Mei-Yin Chien
Introduction: Mei-Yin Chien is a noteworthy inventor based in Tao-Yuan County, Taiwan. With a focus on pharmaceutical advancements, he has made significant strides in the field of medicine. His innovative work primarily addresses bone health and the prevention of bone loss.
Latest Patents: Mei-Yin Chien holds a patent for a pharmaceutical composition designed for the prevention and/or treatment of bone loss. This composition showcases a unique blend of ingredients, including an effective amount of licorice, black bean, Cnidi Fructus, and buckhorn. This invention highlights the potential for natural compounds in developing effective therapies for conditions related to bone health.
Career Highlights: Currently, Mei-Yin Chien is employed at Ko Da Pharmaceuticals Co., Ltd. His role within this reputable company allows him to further explore and expand the applications of his research in the pharmaceutical industry. His dedication to innovation in this field contributes to the overarching goals of improving health outcomes.
Collaborations: Mei-Yin Chien collaborates with talented professionals such as Chao Hsiang Chen and Wen-Mei Fu. These partnerships foster a dynamic research environment, allowing for diverse ideas and expertise to converge in the pursuit of groundbreaking solutions in healthcare.
Conclusion: In summary, Mei-Yin Chien exemplifies the spirit of innovation through his contributions to the pharmaceutical landscape. With his patent addressing vital health issues, and through collaborative efforts with skilled coworkers, he continues to pave the way for advancements in the treatment and prevention of bone loss, ultimately benefiting countless individuals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile